Skip to content
RXRX Recursion Pharmaceuticals, Inc. Class A Common Stock
$5.01 3.35% +0.16
Notify me if price changes either direction
Interactive Brokers Logotype

Buy RXRX stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 2.1B
Enterprise value 1.6B
Trailing PE -2.9378699127739
Forward PE -2.7572253
PEG Ratio -1.1751479651096
Enterprise to EBITDA -2.79
Enterprise to revenue 25.331
Price to book MRQ 2.2457626
Price to sales TTM 32.059338

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter (MRQ) 2025-06-30
Revenue (TTM) 64.6M
EBITDA -586387008
Diluted EPS TTM -1.81
Total Cash (MRQ) 525.1M
Current ratio (MRQ) 3.58
Operating Cash Flow (TTM) -383030016

RXRX trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
75% sells
25% buys
Upgrade Today
In the last 0 months

Recent RXRX News

Trade, Swap & Stake Crypto on Uphold

Buy, sell, and swap crypto. Stake crypto, earn rewards and securely manage 300+ assets—all in one trusted platform. Terms apply. Capital at risk.

Get Started

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.